NasdaqGM - Nasdaq Real Time Price USD
Merus N.V. (MRUS)
40.64
-0.92
(-2.21%)
As of 10:38:05 AM EDT. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 12 | 12 | 14 | 15 |
| Avg. Estimate | -1.14 | -1.15 | -4.56 | -4.29 |
| Low Estimate | -1.29 | -1.32 | -5.33 | -6.57 |
| High Estimate | -0.93 | -1.01 | -3.56 | -0.92 |
| Year Ago EPS | -0.81 | -1.46 | -3.35 | -4.56 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 13 | 13 | 17 | 17 |
| Avg. Estimate | 10.4M | 10.32M | 59.18M | 77.66M |
| Low Estimate | 3M | 3M | 15.8M | 3M |
| High Estimate | 26.8M | 27M | 107.6M | 311.5M |
| Year Ago Sales | 7.33M | 11.77M | 36.13M | 59.18M |
| Sales Growth (year/est) | 41.90% | -12.37% | 63.78% | 31.23% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.75 | -0.85 | -0.9 | -1.06 |
| EPS Actual | -0.81 | -1.46 | -0.49 | -1.4 |
| Difference | -0.06 | -0.61 | 0.41 | -0.34 |
| Surprise % | -8.18% | -72.22% | 45.69% | -31.63% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -1.14 | -1.15 | -4.56 | -4.29 |
| 7 Days Ago | -1.13 | -1.14 | -4.47 | -4.17 |
| 30 Days Ago | -1.07 | -1.09 | -4.21 | -4.09 |
| 60 Days Ago | -1.08 | -1.11 | -4.07 | -4.06 |
| 90 Days Ago | -1.01 | -1.03 | -3.83 | -3.83 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 1 | 1 | 3 |
| Up Last 30 Days | 1 | 1 | 1 | 3 |
| Down Last 7 Days | 7 | 7 | 8 | 6 |
| Down Last 30 Days | 7 | 7 | 8 | 6 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| MRUS | -40.22% | 21.23% | -36.08% | 5.88% |
| S&P 500 | 13.32% | 2.67% | 7.78% | 13.75% |
Upgrades & Downgrades
| Reiterates | Needham: Buy to Buy | 5/19/2025 |
| Maintains | Wells Fargo: Overweight to Overweight | 5/8/2025 |
| Reiterates | Needham: Buy to Buy | 4/9/2025 |
| Reiterates | Guggenheim: Buy to Buy | 3/28/2025 |
| Reiterates | Guggenheim: Buy to Buy | 3/18/2025 |
| Maintains | B of A Securities: Buy to Buy | 3/10/2025 |
Related Tickers
SRRK Scholar Rock Holding Corporation
29.15
-4.58%
ACLX Arcellx, Inc.
56.73
-3.50%
NUVL Nuvalent, Inc.
72.21
-1.51%
BCAX Bicara Therapeutics Inc.
14.28
-1.35%
MLYS Mineralys Therapeutics, Inc.
15.31
-0.26%
RVMD Revolution Medicines, Inc.
38.85
-1.75%
MLTX MoonLake Immunotherapeutics
38.05
+1.13%
CRNX Crinetics Pharmaceuticals, Inc.
30.76
-1.55%
PCVX Vaxcyte, Inc.
31.84
-0.03%
INSM Insmed Incorporated
67.20
-1.35%